ClinicalTrials.Veeva

Menu

Virtual Reality Exposure and Respiratory Relaxation-Based Coping With Cocaine Craving in Cocaine Users (RVCOC)

L

Laboratoire de Psychologie des Cognitions

Status

Completed

Conditions

Virtual Reality Exposure Therapy
Cocaine Use Disorder

Treatments

Behavioral: Respiratory Relaxation
Device: Virtual Reality Exposure to Neutral Cues
Device: Virtual Reality Exposure to Cocaine-Related Cues

Study type

Interventional

Funder types

Other

Identifiers

NCT05557149
2021-A00242-39 (Other Identifier)
RVCOC2021
21.02.14.82513 (Other Identifier)
AAC21-SPA-04 (Other Grant/Funding Number)

Details and patient eligibility

About

Our study main objective is to test whether virtual reality exposure could elicit cocaine craving and its physiological arousal in cocaine users. Investigators aim to compare self-reported cocaine craving, self-efficacy to cope with craving and emotional states levels in 11 voluntary and adults cocaine users in 3 consecutive 10-mins conditions: Neutral VR (virtual reality exposure to neutral stimuli), Cocaine VR (virtual reality exposure to cocaine use-related stimuli) and Relaxation (respiratory relaxation).

Enrollment

11 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Cocaine use within the past 28 days

Exclusion criteria

  • Actual manic or hypomanic episode (MINI, Lecrubier and al., 1998)
  • Actual psychotic episode (MINI, Lecrubier and al., 1998)
  • Actual high suicidal risk (MINI, Lecrubier and al., 1998)
  • Being involved in incarceration procedure
  • Medical risk for safety while physiological arousal (e.g. cardiac disease)
  • Disability for performing virtual reality task (e.g. blindness or deafness)
  • Significant motion sickness symptoms (SSQ pre-post total score ≥ 15, Bimberg et al., 2020)

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

11 participants in 3 patient groups

Neutral VR
Sham Comparator group
Description:
Ten minutes virtual reality exposure to neutral stimuli (e.g. neutral picture frames)
Treatment:
Device: Virtual Reality Exposure to Neutral Cues
Cocaine VR
Experimental group
Description:
Ten minutes virtual reality exposure to cocaine use-related stimuli (i.e. peers using cocaine, cocaine paraphernalia, cocaine use preparing, cocaine use, etc.)
Treatment:
Device: Virtual Reality Exposure to Cocaine-Related Cues
Relaxation
Other group
Description:
Ten minutes respiratory relaxation (eyes closed and sitted on a chair)
Treatment:
Behavioral: Respiratory Relaxation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems